This past Monday, I argued two appeals in the Supreme Court of New Jersey.  They were the Accutane matters discussed here and here.  In the period leading up to those arguments, and the days following, the courts continued to issue opinions.  Here are brief summaries of some of the most significant of those rulings:

Due to an unusual amount of business travel (alas, only to three cold-weather locations) and a hefty appellate brief, I have not been able to keep up with the courts in recent weeks.  Here is a belated, and far from complete, summary of some of the decisions that our appellate courts have made in that time:

Ardan v. Board of Review, ___ N.J. ___ (2018).  In a relatively unusual (for the Supreme Court of New Jersey) 4-3 decision, the Court ruled that the Board of Review proper

Cottrell v. Alcon Laboratories, 874 F.3d 154 (3d Cir. 2017).  Eye drops can be helpful to many people, but putting drops in one’s eyes is unpleasant at many levels.  One of those levels– that prescription eye drop medication is delivered in drop sizes that are too large, resulting in large portions of each drop being wasted by patients–  was the subject of this case.

Consumers brought a class action against manufacturers and distributors of prescription